Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction

Circulation

Volumn 131, Issue 6, 2015, Pages 550-559

  Mohammed, Selma F ^a,b   Hussain, Saad ^a   Mirzoyev, Sultan A ^c   Edwards, William D ^d   Maleszewski, Joseph J ^b   Redfield, Margaret M ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^d Division of Anatomic Pathology   (United States)

Author keywords

autopsy; endothelium; fibrosis; heart failure, diastolic; hypertrophy; microvessels; pathology

Indexed keywords

ADULT; AGED; ARTICLE; AUTOPSY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TRANSTHORACIC ECHOCARDIOGRAPHY; ALGORITHM; ANATOMY AND HISTOLOGY; CARDIOMEGALY; CAUSE OF DEATH; COMORBIDITY; CORONARY BLOOD VESSEL; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENDOMYOCARDIAL FIBROSIS; HEART; HEART FAILURE; HEART MUSCLE; HEART MUSCLE CELL; HEART STROKE VOLUME; ORGAN SIZE; PATHOLOGY; POSTMORTEM CHANGE; REFERENCE VALUE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; AUTOPSY; CARDIOMEGALY; CAUSE OF DEATH; COMORBIDITY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENDOMYOCARDIAL FIBROSIS; FEMALE; HEART; HEART FAILURE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROVESSELS; MYOCARDIUM; MYOCYTES, CARDIAC; ORGAN SIZE; POSTMORTEM CHANGES; REFERENCE VALUES; STROKE VOLUME;

EID: 84922764034     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.009625     Document Type: Article

References (49)

1. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251-259. doi: 10.1056/NEJMoa052256.
2. Mohammed SF, Borlaug BA, Roger VL, Mirzoyev SA, Rodeheffer RJ, Chirinos JA, Redfield MM. Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail. 2012;5:710-719. doi: 10.1161/ CIRCHEARTFAILURE.112.968594.
3. Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62:263-271. doi: 10.1016/j.jacc.2013.02.092.
4. Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med. 2004;350:1953-1959. doi: 10.1056/NEJMoa032566.
5. Lam CS, Roger VL, Rodeheffer RJ, Bursi F, Borlaug BA, Ommen SR, Kass DA, Redfield MM. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation. 2007;115:1982-1990. doi: 10.1161/CIRCULATIONAHA.106.659763.
6. Kawaguchi M, Hay I, Fetics B, Kass DA. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation. 2003;107:714-720.
7. Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, Johnson BD, Redfield MM. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2010;56:845-854. doi: 10.1016/j.jacc.2010.03.077.
8. Phan TT, Abozguia K, Nallur Shivu G, Mahadevan G, Ahmed I, Williams L, Dwivedi G, Patel K, Steendijk P, Ashrafian H, Henning A, Frenneaux M. Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. J Am Coll Cardiol. 2009;54:402-409. doi: 10.1016/j.jacc.2009.05.012.
9. Burke MA, Katz DH, Beussink L, Selvaraj S, Gupta DK, Fox J, Chakrabarti S, Sauer AJ, Rich JD, Freed BH, Shah SJ. Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction. Circ Heart Fail. 2014;7:288-299. doi: 10.1161/ CIRCHEARTFAILURE.113.000854.
10. Chen CH, Nakayama M, Nevo E, Fetics BJ, Maughan WL, Kass DA. Coupled systolic-ventricular and vascular stiffening with age: implications for pressure regulation and cardiac reserve in the elderly. J Am Coll Cardiol. 1998;32:1221-1227.
11. Borbely A, Falcao-Pires I, van Heerebeek L, Hamdani N, Edes I, Gavina C, Leite-Moreira AF, Bronzwaer JG, Papp Z, van der Velden J, Stienen GJ, Paulus WJ. Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ Res. 2009;104:780-786. doi: 10.1161/CIRCRESAHA.108.193326.
12. Borbely A, van der Velden J, Papp Z, Bronzwaer JG, Edes I, Stienen GJ, Paulus WJ. Cardiomyocyte stiffness in diastolic heart failure. Circulation. 2005;111:774-781. doi: 10.1161/01.CIR.0000155257.33485.6D.
13. van Heerebeek L, Borbely A, Niessen HW, Bronzwaer JG, van der Velden J, Stienen GJ, Linke WA, Laarman GJ, Paulus WJ. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation. 2006;113:1966-1973. doi: 10.1161/CIRCULATIONAHA.105.587519.
14. van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, Ijsselmuiden AJ, Schalkwijk CG, Bronzwaer JG, Diamant M, Borbely A, van der Velden J, Stienen GJ, Laarman GJ, Niessen HW, Paulus WJ. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation. 2008;117:43-51. doi: 10.1161/ CIRCULATIONAHA.107.728550.
15. van Heerebeek L, Hamdani N, Falcao-Pires I, Leite-Moreira AF, Begieneman MP, Bronzwaer JG, van der Velden J, Stienen GJ, Laarman GJ, Somsen A, Verheugt FW, Niessen HW, Paulus WJ. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation. 2012;126:830-839. doi: 10.1161/ CIRCULATIONAHA.111.076075.
16. Westermann D, Lindner D, Kasner M, Zietsch C, Savvatis K, Escher F, von Schlippenbach J, Skurk C, Steendijk P, Riad A, Poller W, Schultheiss HP, Tschope C. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail. 2011;4:44-52. doi: 10.1161/ CIRCHEARTFAILURE.109.931451.
17. Kasner M, Westermann D, Lopez B, Gaub R, Escher F, Kuhl U, Schultheiss HP, Tschope C. Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction. J Am Coll Cardiol. 2011;57:977-985. doi: 10.1016/j.jacc.2010.10.024.
18. Goligorsky MS. Microvascular rarefaction: the decline and fall of blood vessels. Organogenesis. 2010;6:1-10.
19. Aroesty JM, McKay RG, Heller GV, Royal HD, Als AV, Grossman W. Simultaneous assessment of left ventricular systolic and diastolic dysfunction during pacing-induced ischemia. Circulation. 1985;71:889-900.
20. Hoenig MR, Bianchi C, Rosenzweig A, Sellke FW. The cardiac microvasculature in hypertension, cardiac hypertrophy and diastolic heart failure. Curr Vasc Pharmacol. 2008;6:292-300.
21. Kitzman DW, Scholz DG, Hagen PT, Ilstrup DM, Edwards WD. Agerelated changes in normal human hearts during the first 10 decades of life. Part II (Maturity): A quantitative anatomic study of 765 specimens from subjects 20 to 99 years old. Mayo Clin Proc. 1988;63:137-146.
22. Edwards WE. Pathology of myocardial infarction and reperfusion. In: Gersh BJ, Rahimtoola SH, eds. Acute Myocardial Infarction. New York: Chapman &Hall; 1997:16-50.
23. van Der Laak JA, Pahlplatz MM, Hanselaar AG, de Wilde PC. Huesaturation-density (HSD) model for stain recognition in digital images from transmitted light microscopy. Cytometry. 2000;39:275-284.
24. Kaul S, Jayaweera AR. Coronary and myocardial blood volumes: noninvasive tools to assess the coronary microcirculation? Circulation. 1997;96:719-724.
25. Kaul S, Jayaweera AR. Myocardial capillaries and coronary flow reserve. J Am Coll Cardiol. 2008;52:1399-1401. doi: 10.1016/j.jacc.2008.07.039.
26. Hiemann NE, Wellnhofer E, Knosalla C, Lehmkuhl HB, Stein J, Hetzer R, Meyer R. Prognostic impact of microvasculopathy on survival after heart transplantation: evidence from 9713 endomyocardial biopsies. Circulation. 2007;116:1274-1282. doi: 10.1161/CIRCULATIONAHA.106.647149.
27. Rakusan K. Verification of coronary angiogenesis by quantitative morphology. Mol Cell Biochem. 2004;264:45-49.
28. Aoki T, Fukumoto Y, Sugimura K, Oikawa M, Satoh K, Nakano M, Nakayama M, Shimokawa H. Prognostic impact of myocardial interstitial fibrosis in non-ischemic heart failure. Comparison between preserved and reduced ejection fraction heart failure.-. Circ J. 2011;75:2605-2613.
29. Roberts WC, Siegel RJ, McManus BM. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol. 1987;60:1340-1355.
30. Rakusan K, Flanagan MF, Geva T, Southern J, Van Praagh R. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation. 1992;86:38-46.
31. Tavora F, Cresswell N, Li L, Ripple M, Fowler D, Burke A. Morphologic features of exertional versus nonexertional sudden death in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2010;105:532-537. doi: 10.1016/j.amjcard.2009.10.022.
32. Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie BM, Carson PE; I-PRESERVE Investigators. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation. 2011;124:2491-2501. doi: 10.1161/CIRCULATIONAHA.110.011031.
33. Choudhury L, Gheorghiade M, Bonow RO. Coronary artery disease in patients with heart failure and preserved systolic function. Am J Cardiol. 2002;89:719-722.
34. Hwang SJ, Melenovsky V, Borlaug BA. Implications of coronary artery disease in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2014;63(25 pt A):2817-2827. doi: 10.1016/j.jacc.2014.03.034.
35. Tsagalou EP, Anastasiou-Nana M, Agapitos E, Gika A, Drakos SG, Terrovitis JV, Ntalianis A, Nanas JN. Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2008;52:1391-1398. doi: 10.1016/j.jacc.2008.05.064.
36. Drakos SG, Kfoury AG, Hammond EH, Reid BB, Revelo MP, Rasmusson BY, Whitehead KJ, Salama ME, Selzman CH, Stehlik J, Clayson SE, Bristow MR, Renlund DG, Li DY. Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. J Am Coll Cardiol. 2010;56:382-391. doi: 10.1016/j. jacc.2010.04.019.
37. Feihl F, Liaudet L, Waeber B, Levy BI. Hypertension: a disease of the microcirculation? Hypertension. 2006;48:1012-1017. doi: 10.1161/01. HYP.0000249510.20326.72.
38. Boodhwani M, Sodha NR, Mieno S, Xu SH, Feng J, Ramlawi B, Clements RT, Sellke FW. Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation. 2007;116(11 suppl):I31-I37. doi: 10.1161/ CIRCULATIONAHA.106.680157.
39. Takemura G, Takatsu Y, Fujiwara H. Luminal narrowing of coronary capillaries in human hypertrophic hearts: an ultrastructural morphometrical study using endomyocardial biopsy specimens. Heart. 1998;79:78-85.
40. Krams R, Kofflard MJ, Duncker DJ, Von Birgelen C, Carlier S, Kliffen M, ten Cate FJ, Serruys PW. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation. 1998;97:230-233.
41. Cecchi F, Sgalambro A, Baldi M, Sotgia B, Antoniucci D, Camici PG, Sciagra R, Olivotto I. Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy. J Cardiovasc Transl Res. 2009;2:452-461. doi: 10.1007/ s12265-009-9142-5.
42. Jayaweera AR, Wei K, Coggins M, Bin JP, Goodman C, Kaul S. Role of capillaries in determining CBF reserve: new insights using myocardial contrast echocardiography. Am J Physiol. 1999;277(6 pt 2):H2363-H2372.
43. Escaned J, Flores A, Garcia-Pavia P, Segovia J, Jimenez J, Aragoncillo P, Salas C, Alfonso F, Hernandez R, Angiolillo DJ, Jimenez-Quevedo P, Banuelos C, Alonso-Pulpon L, Macaya C. Assessment of microcirculatory remodeling with intracoronary flow velocity and pressure measurements: validation with endomyocardial sampling in cardiac allografts. Circulation. 2009;120:1561-1568. doi: 10.1161/CIRCULATIONAHA.108.834739.
44. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123:2856-2869. doi: 10.1161/CIRCULATIONAHA.109.853127.
45. Nama V, Manyonda IT, Onwude J, Antonios TF. Structural capillary rarefaction and the onset of preeclampsia. Obstet Gynecol. 2012;119: 967-974. doi: 10.1097/AOG.0b013e31824ea092.
46. Gutkowska J, Granger JP, Lamarca BB, Danalache BA, Wang D, Jankowski M. Changes in cardiac structure in hypertension produced by placental ischemia in pregnant rats: effect of tumor necrosis factor blockade. J Hypertens. 2011;29:1203-1212. doi: 10.1097/HJH.0b013e3283468392.
47. Bello N, Rendon IS, Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol. 2013;62:1715-1723. doi: 10.1016/j.jacc.2013.08.717.
48. Wilcox JE, Rosenberg J, Vallakati A, Gheorghiade M, Shah SJ. Usefulness of electrocardiographic QT interval to predict left ventricular diastolic dysfunction. Am J Cardiol. 2011;108:1760-1766. doi: 10.1016/j. amjcard.2011.07.050.
49. Ganz P, Hsue PY. Assessment of structural disease in the coronary microvasculature. Circulation. 2009;120:1555-1557. doi: 10.1161/ CIRCULATIONAHA.109.899336